Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Alkelai, Anna ^a   Greenbaum, Lior ^a   Lupoli, Sara ^b,c   Kohn, Yoav ^a   Sarner Kanyas, Kyra ^a   Ben Asher, Edna ^d   Lancet, Doron ^d   Macciardi, Fabio ^c,e   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARAB; ARTICLE; CHROMOSOME 10Q; ETHNIC GROUP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HABP2 GENE; HUMAN; INTRON; ISRAELI; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE ANALYSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; ETHNOLOGY; FAMILY; GENETIC PREDISPOSITION; GENETICS; ISRAEL;

TCF7L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR 7 LIKE 2;

ARABS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; ISRAEL; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84855715016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029228     Document Type: Article

References (73)

1. Alkelai A, Kohn Y, Olender T, Sarner-Kanyas K, Rigbi A, et al. (2009) Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families. Am J Med Genet B Neuropsychiatr Genet 150B: 914-925.
2. Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, et al. (2003) A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet 73: 1355-1367.
3. Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, et al. (2000) Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am J Med Genet 96: 864-869.
4. Lerer B, Segman RH, Hamdan A, Kanyas K, Karni O, et al. (2003) Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry 8: 488-498.
5. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, et al. (2006) Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 78: 315-333.
6. Holliday EG, McLean DE, Nyholt DR, Mowry BJ, (2009) Susceptibility locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit schizophrenia identified by latent class analysis. Arch Gen Psychiatry 66: 1058-1067.
7. Schwab SG, Handoko HY, Kusumawardhani A, Widyawati I, Amir N, et al. (2008) Genome-wide scan in 124 Indonesian sib-pair families with schizophrenia reveals genome-wide significant linkage to a locus on chromosome 3p26-21. Am J Med Genet B Neuropsychiatr Genet 147B: 1245-1252.
8. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, et al. (2009) Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 14: 774-785.
9. Kohn Y, Lerer B, (2005) Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm. Mol Psychiatry 10: 1062-1073.
10. Owen MJ, Craddock N, O'Donovan MC, (2010) Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch Gen Psychiatry 67: 667-673.
11. Alkelai A, Lupoli S, Greenbaum L, Giegling I, Kohn Y, et al. (2011) Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab Israeli sample. FASEB J 25: 4011-4023.
12. Andreasen NC, Endicott J, Spitzer RL, Winokur G, (1977) The family history method using diagnostic criteria. Reliability and validity. Arch Gen Psychiatry 34: 1229-1235.
13. Spitzer R, eds. (1977) The schedule for affective disorders and schizophrenia, lifetime version, 3rd ed New York New York State Psychiatric Institute.
14. Spitzer RL, Endicott J, Robins E, (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773-782.
15. American_Psychiatric_Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed Washington, D.C. American Psychiatric Association.
16. Baron M, Endicott J, Lerer B, Loth JE, Alexander JR, et al. (1994) A pedigree series for mapping disease genes in bipolar affective disorder: sampling, assessment, and analytic considerations. Psychiatr Genet 4: 43-55.
17. Steemers FJ, Gunderson KL, (2005) Illumina, Inc. Pharmacogenomics 6: 777-782.
18. Fan JB, Gunderson KL, Bibikova M, Yeakley JM, Chen J, et al. (2006) Illumina universal bead arrays. Methods Enzymol 410: 57-73.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
20. Van Steen K, Lange C, (2005) PBAT: a comprehensive software package for genome-wide association analysis of complex family-based studies. Hum Genomics 2: 67-69.
21. Lange C, Laird NM, (2002) Power calculations for a general class of family-based association tests: dichotomous traits. Am J Hum Genet 71: 575-584.
22. Ben-David E, Shifman S, (2010) Further investigation of the association between rs7341475 and rs17746501 and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B: 1244-1247.
23. Need AC, Ge D, Weale ME, Maia J, Feng S, et al. (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5: e1000373.
24. Hansen T, Ingason A, Djurovic S, Melle I, Fenger M, et al. (2011) At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia. Biol Psychiatry 70: 59-63.
25. O'Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, et al. (2009) Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry 14: 30-36.
26. Choi-Miura NH, Yoda M, Saito K, Takahashi K, Tomita M, (2001) Identification of the substrates for plasma hyaluronan binding protein. Biol Pharm Bull 24: 140-143.
27. Muhl L, Hersemeyer K, Preissner KT, Weimer T, Kanse SM, (2009) Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions. FEBS Lett 583: 1994-1998.
28. Dimas AS, Dermitzakis ET, (2009) Genetic variation of regulatory systems. Curr Opin Genet Dev 19: 586-590.
29. Nica AC, Montgomery SB, Dimas AS, Stranger BE, Beazley C, et al. (2011) Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet 6: e1000895.
30. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7: e1002003.
31. Kim T, Park JK, Kim HJ, Chung JH, Kim JW, (2010) Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res 178: 266-269.
32. Xu M, St Clair D, He L, (2010) Testing for genetic association between the ZDHHC8 gene locus and susceptibility to schizophrenia: An integrated analysis of multiple datasets. Am J Med Genet B Neuropsychiatr Genet 153B: 1266-1275.
33. Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, et al. (2009) Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 110: 140-148.
34. Kim HJ, Kim MH, Choe BK, Kim JW, Park JK, et al. (2008) Genetic association between 5′-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean population. Schizophr Res 103: 201-208.
35. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, et al. (2008) Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 4: e28.
36. Jaber L, Halpern GJ, Shohat T, (2000) Trends in the frequencies of consanguineous marriages in the Israeli Arab community. Clin Genet 58: 106-110.
37. Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, et al. (2006) AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet 14: 1111-1119.
38. Ingason A, Sigmundsson T, Steinberg S, Sigurdsson E, Haraldsson M, et al. (2007) Support for involvement of the AHI1 locus in schizophrenia. Eur J Hum Genet 15: 988-991.
39. Rivero O, Reif A, Sanjuan J, Molto MD, Kittel-Schneider S, et al. (2010) Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study. PLoS One 5: e12254.
40. Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, et al. (2010) A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 19: 1379-1386.
41. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
42. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. NEJM 355: 241-250.
43. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
44. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, et al. (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39: 218-225.
45. Karns R, Zhang G, Jeran N, Havas-Augustin D, Missoni S, et al. (2011) Replication of genetic variants from genome-wide association studies with metabolic traits in an island population of the Adriatic coast of Croatia. Eur J Hum Genet 19: 341-346.
46. Lin Y, Li P, Cai L, Zhang B, Tang X, et al. (2010) Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet 11: 97.
47. Cruz M, Valladares-Salgado A, Garcia-Mena J, Ross K, Edwards M, et al. (2010) Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab Res Rev 26: 261-270.
48. Ezzidi I, Mtiraoui N, Cauchi S, Vaillant E, Dechaume A, et al. (2009) Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Med Genet 10: 33.
49. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, et al. (2009) Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58: 493-498.
50. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, et al. (2006) Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55: 2654-2659.
51. Mayans S, Lackovic K, Lindgren P, Ruikka K, Agren A, et al. (2007) TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet 15: 342-346.
52. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
53. Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, et al. (2006) Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 84: 1005-1014.
54. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, et al. (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85: 777-782.
55. Tong Y, Lin Y, Zhang Y, Yang J, Liu H, et al. (2009) Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 10: 15.
56. Irvin MR, Wiener HW, Perry RP, Savage RM, Go RC, (2009) Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder. Schizophr Res 114: 50-56.
57. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, et al. (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57: 645-653.
58. Jin T, Liu L, (2008) The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 22: 2383-2392.
59. Lin PI, Shuldiner AR, (2010) Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes. Schizophr Res 123: 234-243.
60. Chien IC, Hsu JH, Lin CH, Bih SH, Chou YJ, et al. (2009) Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr Res 111: 17-22.
61. Bresee LC, Majumdar SR, Patten SB, Johnson JA, (2010) Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 117: 75-82.
62. Holt RI, Bushe C, Citrome L, (2005) Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol 19: 56-65.
63. Saddichha S, Manjunatha N, Ameen S, Akhtar S, (2008) Diabetes and schizophrenia- effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatr Scand 117: 342-347.
64. Verma SK, Subramaniam M, Liew A, Poon LY, (2009) Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 70: 997-1000.
65. Nasrallah HA, (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13: 27-35.
66. Lee S, Lee CE, Elias CF, Elmquist JK, (2009) Expression of the diabetes-associated gene TCF7L2 in adult mouse brain. J Comp Neurol 517: 925-939.
67. Nazwar TA, Glassmann A, Schilling K, (2009) Expression and molecular diversity of Tcf7l2 in the developing murine cerebellum and brain. J Neurosci Res 87: 1532-1546.
68. Murray KD, Choudary PV, Jones EG, (2007) Nucleus- and cell-specific gene expression in monkey thalamus. Proc Natl Acad Sci U S A 104: 1989-1994.
69. Prokunina-Olsson L, Hall JL, (2010) Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut. Diabetologia 53: 712-716.
70. Struewing I, Boyechko T, Barnett C, Beildeck M, Byers SW, et al. (2010) The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3beta-independent manner. Biochem Biophys Res Commun 399: 245-250.
71. Backman M, Machon O, Mygland L, van den Bout CJ, Zhong W, et al. (2005) Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalon. Dev Biol 279: 155-168.
72. Brinkmeier ML, Potok MA, Davis SW, Camper SA, (2007) TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 311: 396-407.
73. Freyberg Z, Ferrando SJ, Javitch JA, (2010) Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167: 388-396.